Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Kamada Ltd.

KMDANASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$8.66
$-0.14(-1.59%)
U.S. Market opens in 13h 37m

Kamada Ltd. Fundamental Analysis

Kamada Ltd. (KMDA) shows moderate financial fundamentals with a PE ratio of 25.50, profit margin of 11.70%, and ROE of 7.89%. The company generates $0.2B in annual revenue with strong year-over-year growth of 12.93%.

Key Strengths

Cash Position13.78%
Current Ratio4.03

Areas of Concern

ROE7.89%
PEG Ratio4.34
We analyze KMDA's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 59.6/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C
59.6/100

We analyze KMDA's fundamental strength across five key dimensions:

Efficiency Score

Weak

KMDA struggles to generate sufficient returns from assets.

ROA > 10%
5.42%

Valuation Score

Weak

KMDA trades at a premium to fair value.

PE < 25
25.50
PEG Ratio < 2
4.34

Growth Score

Excellent

KMDA delivers strong and consistent growth momentum.

Revenue Growth > 5%
12.93%
EPS Growth > 10%
47.06%

Financial Health Score

Excellent

KMDA maintains a strong and stable balance sheet.

Debt/Equity < 1
0.04
Current Ratio > 1
4.03

Profitability Score

Weak

KMDA struggles to sustain strong margins.

ROE > 15%
7.89%
Net Margin ≥ 15%
11.70%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is KMDA Expensive or Cheap?

P/E Ratio

KMDA trades at 25.50 times earnings. This indicates a fair valuation.

25.50

PEG Ratio

When adjusting for growth, KMDA's PEG of 4.34 indicates potential overvaluation.

4.34

Price to Book

The market values Kamada Ltd. at 1.97 times its book value. This may indicate undervaluation.

1.97

EV/EBITDA

Enterprise value stands at 15.36 times EBITDA. This signals the market has high growth expectations.

15.36

How Well Does KMDA Make Money?

Net Profit Margin

For every $100 in sales, Kamada Ltd. keeps $11.70 as profit after all expenses.

11.70%

Operating Margin

Core operations generate 15.88 in profit for every $100 in revenue, before interest and taxes.

15.88%

ROE

Management delivers $7.89 in profit for every $100 of shareholder equity.

7.89%

ROA

Kamada Ltd. generates $5.42 in profit for every $100 in assets, demonstrating efficient asset deployment.

5.42%

Following the Money - Real Cash Generation

Operating Cash Flow

Kamada Ltd. produces operating cash flow of $27.76M, showing steady but balanced cash generation.

$27.76M

Free Cash Flow

Kamada Ltd. generates strong free cash flow of $17.96M, providing ample flexibility for dividends, buybacks, or growth.

$17.96M

FCF Per Share

Each share generates $0.31 in free cash annually.

$0.31

FCF Yield

KMDA converts 3.59% of its market value into free cash.

3.59%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

25.50

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

4.34

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.97

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.92

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.04

vs 25 benchmark

Current Ratio

Current assets to current liabilities

4.03

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.08

vs 25 benchmark

ROA

Return on assets percentage

0.05

vs 25 benchmark

ROCE

Return on capital employed

0.08

vs 25 benchmark

How KMDA Stacks Against Its Sector Peers

MetricKMDA ValueSector AveragePerformance
P/E Ratio25.5029.28 Better (Cheaper)
ROE7.89%820.00% Weak
Net Margin11.70%-19743.00% (disorted) Strong
Debt/Equity0.040.26 Strong (Low Leverage)
Current Ratio4.034.69 Strong Liquidity
ROA5.42%-17807.00% (disorted) Weak

KMDA outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Kamada Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-11.24%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-54.41%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

21.08%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ